Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Acute kidney injury (AKI) following liver transplantation (LT) is associated with increased
costs, morbidity, and mortality. Dexmedetomidine has known have anti-inflammatory effect and
has been shown to ameliorate IRI in several organs. However, the impact of Dexmedetomidine on
AKI after LT is not determined yet. Therefore, this study aims to observe the renal
protective effects of Dexmedetomidine after LT.